Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Cygnal Therapeutics Leader and Scientific Advisory Board Members Co-Author Paper in Cell Alongside Cancer Science Experts

Cygnal Therapeutics 04.16.2020

CIBO Launches Land Intelligence Platform

CiBO Technologies 04.06.2020

Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool

Flagship Pioneering 04.02.2020

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund

Repertoire Immune Medicines 03.25.2020

Seres Therapeutics Appoints Paul Biondi, Experienced Biopharmaceutical Strategy and Corporate Development Professional, to Its Board of Directors

Seres Therapeutics 03.23.2020

Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer

Repertoire Immune Medicines 03.12.2020

Flagship Pioneering Announces Ohana Biosciences

01.27.2020

Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers

01.22.2020

Kintai Therapeutics Appoints Biotech Veteran John Mendlein, Ph.D., as Chairman of the Board of Directors

01.09.2020

Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer

TARIS Biomedical 12.20.2019

Loading